{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:43:30Z","timestamp":1740123810109,"version":"3.37.3"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,2,10]],"date-time":"2023-02-10T00:00:00Z","timestamp":1675987200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,10]],"date-time":"2023-02-10T00:00:00Z","timestamp":1675987200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["P30EY001792"],"award-info":[{"award-number":["P30EY001792"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","award":["Unrestricted Funds"],"award-info":[{"award-number":["Unrestricted Funds"]}],"id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Doc Ophthalmol"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1007\/s10633-023-09923-0","type":"journal-article","created":{"date-parts":[[2023,2,10]],"date-time":"2023-02-10T16:51:23Z","timestamp":1676047883000},"page":"191-197","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Occult retinopathy following treatment of Hepatitis C with glecaprevir\/pibrentasvir (Mavyret)"],"prefix":"10.1007","volume":"146","author":[{"given":"Michael T.","family":"Massengill","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason C.","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Jason","family":"McAnany","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0075-3366","authenticated-orcid":false,"given":"Robert A.","family":"Hyde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,2,10]]},"reference":[{"key":"9923_CR1","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1097\/icu.0000000000000714","volume":"31","author":"MJ Khan","year":"2020","unstructured":"Khan MJ, Papakostas T, Kovacs K, Gupta MP (2020) Drug-induced maculopathy. Curr Opin Ophthalmol 31:563\u2013571. https:\/\/doi.org\/10.1097\/icu.0000000000000714","journal-title":"Curr Opin Ophthalmol"},{"key":"9923_CR2","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1016\/j.ophtha.2018.04.026","volume":"125","author":"WA Pearce","year":"2018","unstructured":"Pearce WA, Chen R, Jain N (2018) Pigmentary maculopathy associated with chronic exposure to pentosan polysulfate sodium. Ophthalmology 125:1793\u20131802. https:\/\/doi.org\/10.1016\/j.ophtha.2018.04.026","journal-title":"Ophthalmology"},{"key":"9923_CR3","doi-asserted-by":"publisher","first-page":"125","DOI":"10.14218\/jcth.2020.00078","volume":"9","author":"X Liu","year":"2021","unstructured":"Liu X, Hu P (2021) Efficacy and safety of glecaprevir\/pibrentasvir in patients with chronic HCV Infection. J Clin Transl Hepatol 9:125\u2013132. https:\/\/doi.org\/10.14218\/jcth.2020.00078","journal-title":"J Clin Transl Hepatol"},{"key":"9923_CR4","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s10633-022-09872-0","volume":"144","author":"AG Robson","year":"2022","unstructured":"Robson AG, Frishman LJ, Grigg J et al (2022) ISCEV Standard for full-field clinical electroretinography (2022 update). Doc Ophthalmol 144:165\u2013177. https:\/\/doi.org\/10.1007\/s10633-022-09872-0","journal-title":"Doc Ophthalmol"},{"key":"9923_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/wco.0b013e328320264c","volume":"22","author":"GE Holder","year":"2009","unstructured":"Holder GE, Gale RP, Acheson JF, Robson AG (2009) Electrodiagnostic assessment in optic nerve disease. Curr Opin Neurol 22:3\u201310. https:\/\/doi.org\/10.1097\/wco.0b013e328320264c","journal-title":"Curr Opin Neurol"},{"key":"9923_CR6","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1038\/sj.eye.6701573","volume":"18","author":"GE Holder","year":"2004","unstructured":"Holder GE (2004) Electrophysiological assessment of optic nerve disease. Eye 18:1133\u20131143. https:\/\/doi.org\/10.1038\/sj.eye.6701573","journal-title":"Eye"},{"key":"9923_CR7","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1590\/s0004-27492011000300017","volume":"74","author":"K Hokazono","year":"2011","unstructured":"Hokazono K, Oyamada MK, Monteiro MLR (2011) Pattern-reversal electroretinograms for the diagnosis and management of disorders of the anterior visual pathway. Arq Bras Oftalmol 74:222\u2013226. https:\/\/doi.org\/10.1590\/s0004-27492011000300017","journal-title":"Arq Bras Oftalmol"},{"key":"9923_CR8","doi-asserted-by":"publisher","first-page":"161","DOI":"10.5935\/0004-2749.20190027","volume":"82","author":"RHC Bertrand","year":"2019","unstructured":"Bertrand RHC, Bertrand ALX, Gomes TM, Ferreira ADSP (2019) An eye on Hepatitis C: a review. Arq Bras Oftalmol 82:161\u2013167. https:\/\/doi.org\/10.5935\/0004-2749.20190027","journal-title":"Arq Bras Oftalmol"},{"key":"9923_CR9","first-page":"1123","volume":"17","author":"A Tsoumani","year":"2013","unstructured":"Tsoumani A, Theopistos V, Katsanos K et al (2013) Treatment and non-treatment related ocular manifestations in patients with chronic Hepatitis B or C. Eur Rev Med Pharmacol 17:1123\u20131131","journal-title":"Eur Rev Med Pharmacol"},{"key":"9923_CR10","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s10384-015-0371-7","volume":"59","author":"Y Miyake","year":"2015","unstructured":"Miyake Y, Tsunoda K (2015) Occult macular dystrophy. Jpn J Ophthalmol 59:71\u201380. https:\/\/doi.org\/10.1007\/s10384-015-0371-7","journal-title":"Jpn J Ophthalmol"},{"key":"9923_CR11","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.4103\/ijo.ijo_786_20","volume":"68","author":"PD Majumder","year":"2020","unstructured":"Majumder PD, Marchese A, Pichi F et al (2020) An update on autoimmune retinopathy. Indian J Ophthalmol 68:1829\u20131837. https:\/\/doi.org\/10.4103\/ijo.ijo_786_20","journal-title":"Indian J Ophthalmol"},{"key":"9923_CR12","doi-asserted-by":"publisher","first-page":"20557","DOI":"10.3390\/molecules191220557","volume":"19","author":"N Pescosolido","year":"2014","unstructured":"Pescosolido N, Barbato A, Pascarella A et al (2014) Role of protease-inhibitors in ocular diseases. Molecules 19:20557\u201320569. https:\/\/doi.org\/10.3390\/molecules191220557","journal-title":"Molecules"}],"container-title":["Documenta Ophthalmologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10633-023-09923-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10633-023-09923-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10633-023-09923-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,7]],"date-time":"2023-04-07T05:11:37Z","timestamp":1680844297000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10633-023-09923-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,10]]},"references-count":12,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["9923"],"URL":"https:\/\/doi.org\/10.1007\/s10633-023-09923-0","relation":{},"ISSN":["0012-4486","1573-2622"],"issn-type":[{"type":"print","value":"0012-4486"},{"type":"electronic","value":"1573-2622"}],"subject":[],"published":{"date-parts":[[2023,2,10]]},"assertion":[{"value":"18 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Financial disclosures"}},{"value":"The statement on animals is not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement on the welfare of animals"}},{"value":"The research followed the tenets of the Declaration of Helsinki and the subjected provided informed consent prior to participating.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}